BioPharmSignal logoBioPharmSignal

Biotech News

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Health (LFST)LifeStance HealthFinancing

SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with

Related news

LFSTLifeStance Health2026-05-08 02:18 EST

LifeStance Health Group Announces Pricing of Secondary Public Offering

LFSTLifeStance Health2026-08-06 10:00 EST

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

View all latest news

LifeStance Health

Outpatient Mental Healthcare LifeStance Health is one of the largest U.S. providers of outpatient mental-health services for children, adolescents and adults. Its clinicians treat a broad range of behavioral-health conditions through therapy and psychiatric care. Hybrid Care Network The company combines in-person practices with virtual...

Recent company news

LFSTLifeStance Health2026-08-06 10:00 EST

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

LFSTLifeStance Health2026-07-16 20:10 EST

LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026

LFSTLifeStance Health2026-05-08 02:18 EST

LifeStance Health Group Announces Pricing of Secondary Public Offering

LFSTLifeStance Health2026-05-07 20:51 EST

LifeStance Health Group Announces Launch of Secondary Public Offering

LFSTLifeStance Health2026-05-07 10:00 EST

LifeStance Reports First Quarter 2026 Results

Stock data

Close
10.66 USD
Market cap
2.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States